A Clinical Trial to Study the effect of Kanakatuka Vati in Malnourished Underweight Children

A Clinical Controlled Trial on Kanakatuka Vati to improve Nutritional Status in Malnourished Underweight Children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019585

Enrollment

Registered

2019-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: E440- Moderate protein-calorie malnutrition Health Condition 3: E440- Moderate protein-calorie malnutrition

Interventions

Intervention1: .Trial drug-Kanakatuka Vati: .Oral administration of 10-20mg/kg/day in divided doses for 30days with madhu and ghrit Control Intervention1: Controlled drug- Hyderabad mixture: Oral adm

Eligibility

Inclusion criteria

Inclusion criteria: .Children between 2 to 6 year of either sex. .Children of grade I and II according to IAP .Classification of malnutrition.

Exclusion criteria

Exclusion criteria: .Children age less than 2 year and more than 6 year .Children of grade III and IV malnutrition.

Design outcomes

Primary

Measure	Time frame
.Improvement in loss of appetite .Effective weight gain .Effective in feverTimepoint: .2 weeks .4 weeks	—

Secondary

Measure	Time frame
.Effective weight gain .Effective in cough Timepoint: .4 weeks .2-3 weeks	—

Countries

India

Contacts

Public ContactDr Laxmi

State Ayurvedic College and Hospital Lucknow

lakshmiomsingh@gmail.com9792446688

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026